IntelGenx Technologies Corp. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 21 rows in 2020. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2020-11-23: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-11-23: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-11-23: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2020-11-23: Reporting owner Godin Andre; Form 4; Security Options (right to buy) p.v.0.00001; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2020-11-23 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 909,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 959,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 1,009,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Godin Andre Officer (President & CFO) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 1,059,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Matzen Dana Officer (VP Bus. Dev., IntelGenxCorp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 384,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Matzen Dana Officer (VP Bus. Dev., IntelGenxCorp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 409,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Matzen Dana Officer (VP Bus. Dev., IntelGenxCorp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 434,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Matzen Dana Officer (VP Bus. Dev., IntelGenxCorp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 459,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 259,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 284,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 309,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Paiement Nadine Officer (VP R & D, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 334,970 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 429,908 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 479,908 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 529,908 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Zerbe Horst G Director, Officer (Chief Executive Officer) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 579,908 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Obeid Rodolphe Officer (VP Operations, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 315,000 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Obeid Rodolphe Officer (VP Operations, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 340,000 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Obeid Rodolphe Officer (VP Operations, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 365,000 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-11-23 | Obeid Rodolphe Officer (VP Operations, IntelGenx Corp.) | 4 | Options (right to buy) p.v.0.00001 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 390,000 owned after | $0.27 exercise price | 2020-11-24 | |
| 2020-08-25 holding as of filing | Godin Andre Officer (President and CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | Holding | 859,970 owned after | $0.58 exercise price | 2020-08-25 |